Key Market Indicators
Irish Antirheumatic Medicine sales are projected to drop by 25% to reach $2.6 million by 2026, starting from $13.2 million in 2021. Since 2013, the Irish market has declined by an average of 9% each year. In 2021, Ireland ranked 20th in the world, after Hungary, which was at $13.2 million. Germany, Spain, and Canada came in second, third, and fourth, respectively.
